Association of Inflammatory Indicators and Clinical Signs and Itch in Atopic Dermatitis Patients Treated with Simiao Pill Combined with Halomethasone Cream
- PMID: 37641704
- PMCID: PMC10460588
- DOI: 10.2147/JIR.S423131
Association of Inflammatory Indicators and Clinical Signs and Itch in Atopic Dermatitis Patients Treated with Simiao Pill Combined with Halomethasone Cream
Abstract
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by symptoms such as itchiness, scaling, and erythema. Previous studies have suggested that inflammatory indicators obtained from peripheral blood cell count can serve as markers for atopic dermatitis pruritus and severity. The objective of this study was to investigate whether these indicators are associated with treatment efficacy in AD patients who received a combination of halomethasone cream and Simiao pill (SMP).
Methods: 131 adult patients diagnosed with AD between January 2020 to August 2022 and treated with topical halometasone ointment combined with oral Simiao pill for a month were recruited and clinical dates of patients were collected. Inflammatory indicators included Eosinophil-to-lymphocyte ratio (ELR), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), serum leukotriene B4 (LTB4), and thymic stromal lymphopoietin (TSLP) and clinical indexes for assessing eczema area and severity index (EASI) and peak pruritus-numerical rating scale (PP-NRS). Relationship of baseline and changes of these Inflammatory indicators and that of clinical indexes were analyzed.
Results: ELR, NLR, LTB4, and TSLP levels have positive association with EASI before treatment, and baseline ELR and LTB4 levels have positive relationship with PP-NRS. ELR, NLR, LTB4, and TSLP showed a significant decrease at week 2 and the low levels were maintained until week 8 after treatment, while no significant changes were observed in levels of MLR and PLR. There was a significant correlation between the decrease of ELR and the decreases of EASI and PP-NRS at weeks 2, 4 and 8 of the treatment.
Conclusion: ELR may serve as an effective and convenient indicator in assessing the disease severity and efficacy of SMP therapy for AD.
Keywords: Simiao pill; atopic dermatitis; clinical efficacy; halometasone cream; inflammatory indicators.
© 2023 Cao et al.
Conflict of interest statement
The authors have declared no competing interests in this work.
Figures

Similar articles
-
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis.J Clin Med. 2023 Mar 12;12(6):2201. doi: 10.3390/jcm12062201. J Clin Med. 2023. PMID: 36983203 Free PMC article.
-
Effect of halometasone cream combined with Simiao pill on the therapeutic effect and expression of serum leukotriene B4 (LTB4) and thymic stromal lymphopoietin (TSLP) in patients with eczema, and the factors influencing its clinical efficacy.Ann Palliat Med. 2021 Nov;10(11):11643-11652. doi: 10.21037/apm-21-2685. Ann Palliat Med. 2021. PMID: 34872289
-
The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis.J Inflamm Res. 2025 Jan 7;18:271-282. doi: 10.2147/JIR.S501883. eCollection 2025. J Inflamm Res. 2025. PMID: 39802504 Free PMC article.
-
Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.Drugs. 2002;62(5):817-40. doi: 10.2165/00003495-200262050-00007. Drugs. 2002. PMID: 11929333 Review.
-
Novel index, neutrophil percentage (%) is a useful marker for disease activity in MOG antibody-associated disease.Mult Scler Relat Disord. 2023 Aug;76:104796. doi: 10.1016/j.msard.2023.104796. Epub 2023 Jun 10. Mult Scler Relat Disord. 2023. PMID: 37320937 Review.
References
-
- Cao J, Liu H, Ding XJ. Effect of halometasone cream combined with Simiao pill on the therapeutic effect and expression of serum leukotriene B4 (LTB4) and thymic stromal lymphopoietin (TSLP) in patients with eczema, and the factors influencing its clinical efficacy. Ann Palliat Med. 2021;10(11):11643–11652. doi:10.21037/apm-21-2685 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous